GoodRx Holdings, Inc.

GDRX Healthcare Health Information Services

GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.

3.36 0.15 −4.27%
Market cap
$1.2B
P/E
62.7×
Fwd P/E
30.9×
Dividend yield
—
F-score
6/9
Altman Z
0.44
Beneish M
−2.40
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — 4 4 3 5 8 6
P/E ratio
138.66 138.66 138.66 138.66 0.00 0.00 0.00 0.00 98.10 30.04
Altman Z-Score
— — — — 8.03 10.37 1.31 1.69 1.36 0.44
P/S ratio
24.64 24.64 24.64 24.64 20.12 17.97 2.54 3.07 2.26 1.21
Altman Z″-Score (non-manufacturers)
— — (9.82) (6.41) 1.22 2.42 1.60 0.96 0.61 (0.18)
P/FCF ratio
75.95 75.95 75.95 75.95 116.01 92.84 21.24 27.94 15.80 10.29
Beneish M-Score
— — — (2.19) (3.66) (2.33) (2.86) (2.70) (2.94) (2.40)
P/Operating CF
304.01 304.01 304.01 304.01 746.21 268.99 61.00 145.32 40.09 29.36
P/B ratio
0.00 0.00 0.00 0.00 15.58 16.11 2.39 3.03 2.48 1.57
Price to Tangible BV
0.00 0.00 0.00 0.00 26.81 32.43 6.88 7.94 6.85 7.92
EV/Sales
25.93 25.93 25.93 25.93 19.57 17.60 2.41 3.05 2.32 1.50
EV/EBITDA
70.22 70.22 70.22 70.22 0.00 255.30 31.12 27.25 13.32 6.83
EV/Operating CF
73.20 73.20 73.20 73.20 82.05 73.39 12.58 16.56 9.99 7.10
EV/FCF
79.93 79.93 79.93 79.93 112.82 90.91 20.16 27.75 16.18 12.70
Quick Ratio
0.00 0.00 4.09 2.22 17.47 13.06 11.46 6.66 4.80 2.02
Current Ratio
— — 4.40 2.59 18.24 13.42 12.05 7.12 5.32 2.61
Net Debt/EBITDA
0.79 1.99 7.79 4.12 1.20 (5.41) (1.66) (0.19) 0.31 1.30
Debt/Assets
15.54% 0.00% 229.43% 173.46% 45.36% 41.23% 41.06% 41.32% 35.42% 34.78%
Debt/Equity
5.75 (1.58) (1.70) (1.91) 0.94 0.80 0.81 0.86 0.68 0.79
Asset Turnover
0.34 1.06 0.82 1.11 0.59 0.48 0.48 0.47 0.53 0.57
Operating CF/Net income
0.00 0.00 3.18 1.95 (0.45) (7.08) (4.47) (15.59) 11.22 5.52
Capex/Depreciation
— — (0.31) (0.34) (1.64) (0.91) (0.96) (0.50) (0.98) (0.85)
Interest Coverage
10.62 14.39 3.48 2.82 (9.88) 0.57 0.05 (0.48) 1.24 2.05
ROE
3.77% (4.29%) (2.01%) (3.80%) 156.09% (3.27%) (3.99%) (1.12%) 2.21% 4.54%
ROA
(2.67%) 5.98% 4.66% 12.19% (31.62%) (1.64%) (2.04%) (0.56%) 1.10% 2.18%
ROIC
0.00% 0.00% 18.41% 29.66% (42.37%) 1.51% 0.15% (2.26%) 5.36% 6.49%
Return on Tangible Assets
0.00% 0.00% 24.77% 77.62% (27.97%) (2.45%) (3.80%) (1.16%) 2.99% 7.44%
Average Days of Receivables
0.00 0.00 48.80 45.25 45.55 57.82 55.78 69.86 67.23 107.98
Research and Development Expense of Revenue
5.78% 7.31% 17.59% 7.55% 11.22% 16.88% 18.67% 18.11% 15.62% 15.19%
Selling, General and Administrative Expense of Revenue
64.80% 52.95% 45.10% 49.37% 130.12% 70.42% 65.54% 62.22% 61.21% 55.91%
Intangible Assets out of Total Assets
0.00 0.00 0.75 0.67 0.20 0.26 0.33 0.30 0.33 0.35
Share Based Compensation of Revenue
0.00% 0.00% 0.71% 0.97% 72.14% 21.53% 15.69% 13.97% 12.50% 9.62%
Graham Net Nets
0.02 0.02 0.02 0.02 0.03 0.02 0.07 0.02 0.00 (0.15)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.42 1.87
Earnings Yield
0.72% 0.72% 0.72% 0.72% (2.66%) (0.17%) (1.66%) (0.32%) 1.02% 3.33%
Free Cash Flow Yield
1.32% 1.32% 1.32% 1.32% 0.86% 1.08% 4.71% 3.58% 6.33% 9.72%
Revenue per Share
0.26 0.41 2.23 1.71 2.00 1.82 1.86 1.83 2.05 2.24
Operating CF per Share
0.00 0.00 0.40 0.37 0.48 0.44 0.36 0.34 0.48 0.47
Capex per Share
0.00 0.00 (0.03) (0.03) (0.13) (0.08) (0.13) (0.14) (0.18) (0.21)
Free Cash Flow per Share
0.00 0.00 0.37 0.34 0.35 0.35 0.22 0.20 0.29 0.26
Cash per Share
0.06 0.05 0.31 0.12 3.54 2.30 1.83 1.64 1.16 0.73
Shareholders Equity per Share
0.02 (0.22) (3.80) (1.55) 2.59 2.03 1.97 1.86 1.88 1.73
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.02 (0.22) (3.80) (1.55) 2.59 2.03 1.97 1.86 1.88 1.73
Free Cash Flow
— — 41.80 77.54 95.52 144.32 91.57 82.53 113.55 93.88
Working Capital
— — 56.45 53.21 1,026.82 1,007.71 843.37 750.23 535.35 397.10
Capital Expenditures
— — (3.46) (5.75) (35.82) (34.46) (55.21) (55.77) (70.35) (74.02)
Net Current Asset Value
(46.00) (136.00) (667.14) (650.79) 327.61 312.88 129.88 45.95 (4.15) (144.69)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 978.66 1,062.27 0.00 27.90 13.63
Capex to Sales
0.00 0.00 0.01 0.01 0.07 0.05 0.07 0.07 0.09 0.09
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 999.42 1,118.85 0.00 27.24 11.04
Other line items
Depreciation/Fixed assets
— — 11.18 9.12 0.95 1.76 2.91 6.97 5.69 7.09
Cash ROIC
0.00% 0.00% 12.61% 22.38% 4.06% 5.93% 4.10% 3.95% 6.82% 6.87%
Accounts Receivable Turnover
0.00 0.00 6.16 9.53 9.43 7.98 6.52 5.75 5.47 4.18
Accounts Payable Turnover
0.00 0.00 0.80 1.86 3.26 3.36 3.70 2.48 1.91 3.43
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 435.46 204.45 126.95 136.74 99.27 197.79 107.02 122.97
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
— — 40.50 40.74 58.43 93.40 117.61 130.37 144.77 190.84
Average Payables
— — 7.50 7.53 9.07 13.90 17.60 26.98 25.20 16.77
Average Assets
291.50 148.00 305.40 350.79 928.46 1,538.87 1,606.13 1,596.72 1,488.43 1,396.06
Average Common Equity
(206.00) (206.00) (707.71) (1,125.00) (188.11) 771.52 823.25 788.39 743.31 670.46

Fold the line items

Columns are period end dates